Evaluation of UMELISA® T4 NEONATAL and UMELISA® T4 using polystyrene plates coated with anti-thyroxine (T4) monoclonal antibodies

• Published in: Journal of immunoassay & immunochemistry 2018-01, Vol.39 (1), p.30-42
• Main Authors: Castells, Elisa M., González, Ernesto C, Pérez, Pedro L, Del Río, Lesley, Tejeda, Yileidis, Perea, Yenitse, Martín, Odalys, Espinosa, Maryeris, Rivero, Jose A., Frómeta, Amarilys
• Format: Article
• Language: English
• Subjects: Abbreviations; Antibodies, Monoclonal - chemistry; Antibodies, Monoclonal - immunology; Calibration; Coating; Coefficient of variation; Congenital hypothyroidism; Correlation analysis; Dilution; Enzyme-linked immunosorbent assay; Enzyme-Linked Immunosorbent Assay - instrumentation; Enzyme-Linked Immunosorbent Assay - methods; Enzyme-Linked Immunosorbent Assay - standards; Enzymes; Humans; Hypothyroidism; Immunoassay; Immunoglobulin G; Immunoglobulins; Mathematical analysis; Monoclonal antibodies; Neonates; Plates; Polystyrene; Polystyrene resins; Polystyrenes - chemistry; Sheep; Standardization; SUMA technology; Thyroid; Thyroid gland; Thyroid-stimulating hormone; Thyroxine; thyroxine (T4); Thyroxine - immunology; ultra-microELISA
• ISSN: 1532-1819; 1532-4230
• DOI: 10.1080/15321819.2017.1392321

Congenital hypothyroidism is one of the most common preventable causes of mental retardation. The Center of Immunoassay has developed the UMELISA® T4 NEONATAL and UMELISA® T4 to determine neonatal T4 levels in dried blood and serum samples. Both reagent kits use the same polystyrene plates coated with anti-thyroxine (T4) polyclonal antibodies as solid phase. This work shows the re-standardization of the UMELISA® T4 NEONATAL and UMELISA® T4 using plates coated with anti-T4 monoclonal antibodies (T4Mabs). Polystyrene plates of the modified assays were firstly coated with polyclonal IgG sheep-anti-mouse IgG for 18 hours. T4Mabs were added to the plates and incubated for 2 hours at room temperature. Different performance parameters were evaluated and correlation studies with the commercial kits done. Using polystyrene plates coated with T4Mabs increases the slope of the calibration curve in the clinical interest zone. The assay conjugates work twice diluted in respect to the ones of the commercial kits. Recovery percentages (90.8-110.7 for UMELISA® T4 NEONATAL and 92.1-109.3 for UMELISA® T4) and intra (7.2-7.6 for UMELISA® T4 NEONATAL and 6.9-7.2 for UMELISA® T4) and inter (7.4-8.5 for UMELISA® T4 NEONATAL and 7.1-8.5 for UMELISA® T4) coefficients of variation were similar to the ones described for the commercial kits. Limits of detection and quantification were 9.0 and 21.1 nmol/L for UMELISA® T4 NEONATAL, and 8.9 and 20.5 nmol/L for UMELISA® T4, respectively. The results also showed high overall concordance between assays (n = 244, r = 0.92, ρc = 0.91 for UMELISA® T4 NEONATAL and n = 492, r = 0.92, ρc = 0.9 for UMELISA® T4). The analytical sensibility of UMELISA® T4 NEONATAL and UMELISA® T4 is improved by using polystyrene plates coated with T4Mabs, without affecting the precision and accuracy of the results. Abbreviations: T4: L-Thyroxine; ELISA: Enzyme-linked immunosorbent assay; SUMA: Ultra Micro Analytic System; UMELISA: Ultramicro enzyme-linked immunosorbent assay; TSH: Thyroid-stimulating hormone.